LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.60 | 27.76 | 948 | 7045 | 0.1346 | 0.5559 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.60 | 27.76 | 1525 | 7045 | 0.2164 | 0.6513 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.31 | 27.76 | 11 | 6976 | 0.0016 | -0.1096 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.31 | 27.76 | 1062 | 6976 | 0.1522 | 0.5794 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.31 | 27.76 | 688 | 6976 | 0.0986 | 0.4957 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.31 | 27.76 | 1520 | 6976 | 0.2179 | 0.6521 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.01 | 27.76 | 10 | 7000 | 0.0014 | -0.1201 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.01 | 27.76 | 1067 | 7000 | 0.1524 | 0.5799 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.01 | 27.76 | 729 | 7000 | 0.1041 | 0.5063 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.01 | 27.76 | 1550 | 7000 | 0.2214 | 0.6556 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 83.72 | 27.76 | 10 | 7055 | 0.0014 | -0.1200 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 83.72 | 27.76 | 1071 | 7055 | 0.1518 | 0.5796 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 83.72 | 27.76 | 698 | 7055 | 0.0989 | 0.4972 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 83.72 | 27.76 | 1554 | 7055 | 0.2203 | 0.6550 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.42 | 27.76 | 8 | 7025 | 0.0011 | -0.1443 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.42 | 27.76 | 1086 | 7025 | 0.1546 | 0.5829 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.42 | 27.76 | 681 | 7025 | 0.0969 | 0.4931 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.42 | 27.76 | 1561 | 7025 | 0.2222 | 0.6565 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.13 | 27.76 | 11 | 6987 | 0.0016 | -0.1096 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.13 | 27.76 | 1113 | 6987 | 0.1593 | 0.5885 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.13 | 27.76 | 727 | 6987 | 0.1040 | 0.5059 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.13 | 27.76 | 1579 | 6987 | 0.2260 | 0.6597 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 88.84 | 27.76 | 10 | 6965 | 0.0014 | -0.1202 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 88.84 | 27.76 | 1127 | 6965 | 0.1618 | 0.5915 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 88.84 | 27.76 | 608 | 6965 | 0.0873 | 0.4729 | MN20160318_Q01 | N12 |